Corporate innovation strategy and sales revenue of multinational companies in times of crisis: A case of the COVID-19 pandemic

Mosie C. C. Molate; Collins C. Ngwakwe; Kgobalale N. Motubatse

Journal menu

Corporate innovation strategy and sales revenue of multinational companies in times of crisis: A case of the COVID-19 pandemic

Download This Article

Mosie C. C. Molate , Collins C. Ngwakwe , Kgobalale N. Motubatse

https://doi.org/10.22495/cbsrv6i1siart13

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Businesses varied in their experiences during the COVID-19 crisis, some faced significant difficulties while others thrived (Hu & Zhang, 2021). Over the past three decades, literature has demonstrated that a company’s success during turbulent business and stable environments is increasingly influenced by intangible resources rather than tangible ones (Masood et al., 2017). This study aims to explore the impact of corporate innovation (CI) strategy on sales revenue (SR) during the COVID-19 pandemic. The study is quantitative, based on a sample of 74 global companies that were identified as thriving during the pandemic by the Financial Times. Data for the period 2019–2021 was analyzed using a Pearson pairwise correlation matrix and cross-sectional regression analysis. Our findings revealed a positive and statistically significant correlation between CI and SR. However, the direct impact of the CI strategy on SR was found to be statistically insignificant. These findings suggest that while CI strategy may not have an immediate impact on SR, it is crucial for sustaining SR, even during the recent COVID-19 crisis.

Keywords: Competitive Advantage, Corporate Innovation, Pandemic, Resource-Based Theory, Sales Revenue

Authors’ individual contribution: Conceptualization — M.C.C.M.; Methodology — M.C.C.M.; Investigation — M.C.C.M.; Data Curation — M.C.C.M.; Writing — M.C.C.M.; Supervision — C.C.N. and K.N.M.

Declaration of conflicting interests: The Authors declare that there is no conflict of interest.

JEL Classification: L250, M40, M100

Received: 04.06.2024
Revised: 10.09.2024; 07.02.2025
Accepted: 04.03.2025
Published online: 07.03.2025

How to cite this paper: Molate, M. C. C., Ngwakwe, C. C., & Motubatse, K. N. (2025). Corporate innovation strategy and sales revenue of multinational companies in times of crisis: A case of the COVID-19 pandemic [Special issue]. Corporate & Business Strategy Review, 6(1), 370–377. https://doi.org/10.22495/cbsrv6i1siart13